My Quote Request
6505-01-156-1680
20 Products
UPC74300-00062
METHYL SALICYLATE AND MENTHOL OINTMENT
NSN, MFG P/N
6505011561680
NSN
6505-01-156-1680
UPC74300-00062
METHYL SALICYLATE AND MENTHOL OINTMENT
NSN, MFG P/N
6505011561680
NSN
6505-01-156-1680
MFG
PFIZER INC LEEMING/PACQUIN DIV
Description
ACTIVE INGREDIENT AND STRENGTH: 15.000 METHYL SALICYLATE PERCENTAGE, W/W AND 10.000 MENTHOL PERCENTAGE, W/W
III PART NAME ASSIGNED BY CONTROLLING AGENCY: METHYL SALICYLATE AND MENTHOL OINTMENT 3OZ (85 GRAM) 12S
MEDICAMENT BASE TYPE: EMULSION BASE, OIL-IN-WATER
PRIMARY CONTAINER CONTENT QUANTITY: 3.000 OUNCES
PRIMARY CONTAINER TYPE: TUBE, COLLAPSIBLE
TOTAL PRIMARY CONTAINER QUANTITY: 12
Related Searches:
FUNDUSCEIN-10
FLUORESCEIN INJECTION,USP
NSN, MFG P/N
6505011561602
NSN
6505-01-156-1602
FUNDUSCEIN-10
FLUORESCEIN INJECTION,USP
NSN, MFG P/N
6505011561602
NSN
6505-01-156-1602
MFG
COOPER LABORATORIES INC COOPER VISION PHARMACEUTICALS INC DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 100.000 MILLIGRAMS FLUORESCEIN SODIUM PER MILLILITER
ADMINISTRATION: INTRAVENOUS
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 5.000 MILLILITERS
PRIMARY CONTAINER TYPE: AMPUL
TOTAL PRIMARY CONTAINER QUANTITY: 12
Related Searches:
NDC00058-0300-40
FLUORESCEIN INJECTION,USP
NSN, MFG P/N
6505011561602
NSN
6505-01-156-1602
NDC00058-0300-40
FLUORESCEIN INJECTION,USP
NSN, MFG P/N
6505011561602
NSN
6505-01-156-1602
MFG
COOPER LABORATORIES INC COOPER VISION PHARMACEUTICALS INC DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 100.000 MILLIGRAMS FLUORESCEIN SODIUM PER MILLILITER
ADMINISTRATION: INTRAVENOUS
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 5.000 MILLILITERS
PRIMARY CONTAINER TYPE: AMPUL
TOTAL PRIMARY CONTAINER QUANTITY: 12
Related Searches:
72001
FLURAZEPAM HYDROCHLORIDE CAPSULES,USP
NSN, MFG P/N
6505011561604
NSN
6505-01-156-1604
72001
FLURAZEPAM HYDROCHLORIDE CAPSULES,USP
NSN, MFG P/N
6505011561604
NSN
6505-01-156-1604
MFG
HOFFMANN-LA ROCHE INC.
Description
(NON-CORE DATA) EXTERIOR CONTAINER CUBIC MEASURE: 0.37 CUBIC FEET
(NON-CORE DATA) EXTERIOR CONTAINER QUANTITY: 36
(NON-CORE DATA) EXTERIOR CONTAINER WEIGHT: 7.00 POUNDS
(NON-CORE DATA) UNIT OF ISSUE CUBE: 0.01 CUBIC FEET
(NON-CORE DATA) UNIT OF ISSUE WEIGHT: 0.20 POUNDS
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 15.000 MILLIGRAMS FLURAZEPAM HYDROCHLORIDE ACTIVE INGREDIENT
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: FLURAZEPAM HYDROCHLORIDE CAPSULES USP 15MG 100S BT
PRIMARY CONTAINER TYPE: BOTTLE
PROTECTIVE STORAGE FEATURE: SECURITY STORAGE
Related Searches:
DALMANE
FLURAZEPAM HYDROCHLORIDE CAPSULES,USP
NSN, MFG P/N
6505011561604
NSN
6505-01-156-1604
DALMANE
FLURAZEPAM HYDROCHLORIDE CAPSULES,USP
NSN, MFG P/N
6505011561604
NSN
6505-01-156-1604
MFG
HOFFMANN-LA ROCHE INC.
Description
(NON-CORE DATA) EXTERIOR CONTAINER CUBIC MEASURE: 0.37 CUBIC FEET
(NON-CORE DATA) EXTERIOR CONTAINER QUANTITY: 36
(NON-CORE DATA) EXTERIOR CONTAINER WEIGHT: 7.00 POUNDS
(NON-CORE DATA) UNIT OF ISSUE CUBE: 0.01 CUBIC FEET
(NON-CORE DATA) UNIT OF ISSUE WEIGHT: 0.20 POUNDS
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 15.000 MILLIGRAMS FLURAZEPAM HYDROCHLORIDE ACTIVE INGREDIENT
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: FLURAZEPAM HYDROCHLORIDE CAPSULES USP 15MG 100S BT
PRIMARY CONTAINER TYPE: BOTTLE
PROTECTIVE STORAGE FEATURE: SECURITY STORAGE
Related Searches:
NDC00140-0065-01
FLURAZEPAM HYDROCHLORIDE CAPSULES,USP
NSN, MFG P/N
6505011561604
NSN
6505-01-156-1604
NDC00140-0065-01
FLURAZEPAM HYDROCHLORIDE CAPSULES,USP
NSN, MFG P/N
6505011561604
NSN
6505-01-156-1604
MFG
HOFFMANN-LA ROCHE INC.
Description
(NON-CORE DATA) EXTERIOR CONTAINER CUBIC MEASURE: 0.37 CUBIC FEET
(NON-CORE DATA) EXTERIOR CONTAINER QUANTITY: 36
(NON-CORE DATA) EXTERIOR CONTAINER WEIGHT: 7.00 POUNDS
(NON-CORE DATA) UNIT OF ISSUE CUBE: 0.01 CUBIC FEET
(NON-CORE DATA) UNIT OF ISSUE WEIGHT: 0.20 POUNDS
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 15.000 MILLIGRAMS FLURAZEPAM HYDROCHLORIDE ACTIVE INGREDIENT
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: FLURAZEPAM HYDROCHLORIDE CAPSULES USP 15MG 100S BT
PRIMARY CONTAINER TYPE: BOTTLE
PROTECTIVE STORAGE FEATURE: SECURITY STORAGE
Related Searches:
NDC00140-0066-01
FLURAZEPAM HYDROCHLORIDE CAPSULES,USP
NSN, MFG P/N
6505011561606
NSN
6505-01-156-1606
NDC00140-0066-01
FLURAZEPAM HYDROCHLORIDE CAPSULES,USP
NSN, MFG P/N
6505011561606
NSN
6505-01-156-1606
MFG
HOFFMANN-LA ROCHE INC.
Description
(NON-CORE DATA) EXTERIOR CONTAINER CUBIC MEASURE: 0.35 CUBIC FEET
(NON-CORE DATA) EXTERIOR CONTAINER QUANTITY: 36
(NON-CORE DATA) EXTERIOR CONTAINER WEIGHT: 15.00 POUNDS
(NON-CORE DATA) UNIT OF ISSUE CUBE: 0.009 CUBIC FEET
(NON-CORE DATA) UNIT OF ISSUE WEIGHT: 0.42 POUNDS
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 30.000 MILLIGRAMS FLURAZEPAM HYDROCHLORIDE ACTIVE INGREDIENT
CAPSULE CONTENT FORM: POWDER
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: LURAZEPAM HYDROCHLORIDE CAPSULES USP 30MG 100S BT
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00591-5615-01
FLURAZEPAM HYDROCHLORIDE CAPSULES,USP
NSN, MFG P/N
6505011561606
NSN
6505-01-156-1606
NDC00591-5615-01
FLURAZEPAM HYDROCHLORIDE CAPSULES,USP
NSN, MFG P/N
6505011561606
NSN
6505-01-156-1606
MFG
DANBURY PHARMACAL INC
Description
(NON-CORE DATA) EXTERIOR CONTAINER CUBIC MEASURE: 0.35 CUBIC FEET
(NON-CORE DATA) EXTERIOR CONTAINER QUANTITY: 36
(NON-CORE DATA) EXTERIOR CONTAINER WEIGHT: 15.00 POUNDS
(NON-CORE DATA) UNIT OF ISSUE CUBE: 0.009 CUBIC FEET
(NON-CORE DATA) UNIT OF ISSUE WEIGHT: 0.42 POUNDS
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 30.000 MILLIGRAMS FLURAZEPAM HYDROCHLORIDE ACTIVE INGREDIENT
CAPSULE CONTENT FORM: POWDER
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: LURAZEPAM HYDROCHLORIDE CAPSULES USP 30MG 100S BT
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00781-2807-01
FLURAZEPAM HYDROCHLORIDE CAPSULES,USP
NSN, MFG P/N
6505011561606
NSN
6505-01-156-1606
NDC00781-2807-01
FLURAZEPAM HYDROCHLORIDE CAPSULES,USP
NSN, MFG P/N
6505011561606
NSN
6505-01-156-1606
MFG
SANDOZ INC.
Description
(NON-CORE DATA) EXTERIOR CONTAINER CUBIC MEASURE: 0.35 CUBIC FEET
(NON-CORE DATA) EXTERIOR CONTAINER QUANTITY: 36
(NON-CORE DATA) EXTERIOR CONTAINER WEIGHT: 15.00 POUNDS
(NON-CORE DATA) UNIT OF ISSUE CUBE: 0.009 CUBIC FEET
(NON-CORE DATA) UNIT OF ISSUE WEIGHT: 0.42 POUNDS
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 30.000 MILLIGRAMS FLURAZEPAM HYDROCHLORIDE ACTIVE INGREDIENT
CAPSULE CONTENT FORM: POWDER
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: LURAZEPAM HYDROCHLORIDE CAPSULES USP 30MG 100S BT
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
EFUDEX SOLUTION
FLUOROURACIL TOPICAL SOLUTION,USP
NSN, MFG P/N
6505011561654
NSN
6505-01-156-1654
EFUDEX SOLUTION
FLUOROURACIL TOPICAL SOLUTION,USP
NSN, MFG P/N
6505011561654
NSN
6505-01-156-1654
MFG
HOFFMANN-LA ROCHE INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 5.000 PERCENTAGE, W/V FLUOROURACIL ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: FLUOROURACIL TOPICAL SOLUTION USP 10ML BT
PRIMARY CONTAINER CONTENT QUANTITY: 10.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE, DROPPER
Related Searches:
NDC00004-1705-06
FLUOROURACIL TOPICAL SOLUTION,USP
NSN, MFG P/N
6505011561654
NSN
6505-01-156-1654
NDC00004-1705-06
FLUOROURACIL TOPICAL SOLUTION,USP
NSN, MFG P/N
6505011561654
NSN
6505-01-156-1654
MFG
HOFFMANN-LA ROCHE INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 5.000 PERCENTAGE, W/V FLUOROURACIL ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: FLUOROURACIL TOPICAL SOLUTION USP 10ML BT
PRIMARY CONTAINER CONTENT QUANTITY: 10.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE, DROPPER
Related Searches:
ARISTOSPAN
TRIAMCINOLONE HEXACETONIDE INJECTION
NSN, MFG P/N
6505011561663
NSN
6505-01-156-1663
ARISTOSPAN
TRIAMCINOLONE HEXACETONIDE INJECTION
NSN, MFG P/N
6505011561663
NSN
6505-01-156-1663
MFG
ASTELLAS PHARMA US INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 5.000 MILLIGRAMS TRIAMCINOLONE HEXACETONIDE PER MILLILITER
III PART NAME ASSIGNED BY CONTROLLING AGENCY: TRIAMCINOLONE HEXACETONIDE INJECTION 5MG/ML 5ML VIAL
PRIMARY CONTAINER CONTENT QUANTITY: 5.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: IN A 5 ML VIAL
TOTAL PRIMARY CONTAINER QUANTITY: 1
Related Searches:
NDC00469-5118-05
TRIAMCINOLONE HEXACETONIDE INJECTION
NSN, MFG P/N
6505011561663
NSN
6505-01-156-1663
NDC00469-5118-05
TRIAMCINOLONE HEXACETONIDE INJECTION
NSN, MFG P/N
6505011561663
NSN
6505-01-156-1663
MFG
ASTELLAS PHARMA US INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 5.000 MILLIGRAMS TRIAMCINOLONE HEXACETONIDE PER MILLILITER
III PART NAME ASSIGNED BY CONTROLLING AGENCY: TRIAMCINOLONE HEXACETONIDE INJECTION 5MG/ML 5ML VIAL
PRIMARY CONTAINER CONTENT QUANTITY: 5.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: IN A 5 ML VIAL
TOTAL PRIMARY CONTAINER QUANTITY: 1
Related Searches:
NDC54643-1054-00
TRIAMCINOLONE HEXACETONIDE INJECTION
NSN, MFG P/N
6505011561663
NSN
6505-01-156-1663
NDC54643-1054-00
TRIAMCINOLONE HEXACETONIDE INJECTION
NSN, MFG P/N
6505011561663
NSN
6505-01-156-1663
MFG
SANDOZ CONSUMER HEALTH CARE GROUP
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 5.000 MILLIGRAMS TRIAMCINOLONE HEXACETONIDE PER MILLILITER
III PART NAME ASSIGNED BY CONTROLLING AGENCY: TRIAMCINOLONE HEXACETONIDE INJECTION 5MG/ML 5ML VIAL
PRIMARY CONTAINER CONTENT QUANTITY: 5.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: IN A 5 ML VIAL
TOTAL PRIMARY CONTAINER QUANTITY: 1
Related Searches:
NDC00028-0020-01
IMIPRAMINE PAMOATE CAPSULES
NSN, MFG P/N
6505011561664
NSN
6505-01-156-1664
NDC00028-0020-01
IMIPRAMINE PAMOATE CAPSULES
NSN, MFG P/N
6505011561664
NSN
6505-01-156-1664
MFG
CIBA-GEIGY CORP GEIGY PHARMACEUTICALS DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 75.000 MILLIGRAMS IMIPRAMINE PAMOATE EQUIVALENT
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: IMIPRAMINE PAMOATE CAPSULES 75MG 100S BT
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00406-9923-01
IMIPRAMINE PAMOATE CAPSULES
NSN, MFG P/N
6505011561664
NSN
6505-01-156-1664
NDC00406-9923-01
IMIPRAMINE PAMOATE CAPSULES
NSN, MFG P/N
6505011561664
NSN
6505-01-156-1664
MFG
MALLINCKRODT INC ANESTHESIA PRODUCTS
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 75.000 MILLIGRAMS IMIPRAMINE PAMOATE EQUIVALENT
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: IMIPRAMINE PAMOATE CAPSULES 75MG 100S BT
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
TOFRANIL-PM
IMIPRAMINE PAMOATE CAPSULES
NSN, MFG P/N
6505011561664
NSN
6505-01-156-1664
TOFRANIL-PM
IMIPRAMINE PAMOATE CAPSULES
NSN, MFG P/N
6505011561664
NSN
6505-01-156-1664
MFG
CIBA-GEIGY CORP GEIGY PHARMACEUTICALS DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 75.000 MILLIGRAMS IMIPRAMINE PAMOATE EQUIVALENT
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: IMIPRAMINE PAMOATE CAPSULES 75MG 100S BT
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC--0161-0620-20#
PLASMA COAGULATION
NSN, MFG P/N
6505011561679
NSN
6505-01-156-1679
NDC--0161-0620-20#
PLASMA COAGULATION
NSN, MFG P/N
6505011561679
NSN
6505-01-156-1679
MFG
CUTTER LABORATORIES INC
Description
GENERAL CHARACTERISTICS ITEM DESCRIPTION: PLASMA COAGULATION FRACTION LYOPH STER 500 UNITS PACKAGE CONTAINS 20 ML STERILE WATER FOR INJECTION COAGULATION FACTORS II,VII,IX,X WITH MINIMAL AMOUNT OF TOTAL PROTEIN
Related Searches:
BEN-GAY
METHYL SALICYLATE AND MENTHOL OINTMENT
NSN, MFG P/N
6505011561680
NSN
6505-01-156-1680
BEN-GAY
METHYL SALICYLATE AND MENTHOL OINTMENT
NSN, MFG P/N
6505011561680
NSN
6505-01-156-1680
MFG
PFIZER INC LEEMING/PACQUIN DIV
Description
ACTIVE INGREDIENT AND STRENGTH: 15.000 METHYL SALICYLATE PERCENTAGE, W/W AND 10.000 MENTHOL PERCENTAGE, W/W
III PART NAME ASSIGNED BY CONTROLLING AGENCY: METHYL SALICYLATE AND MENTHOL OINTMENT 3OZ (85 GRAM) 12S
MEDICAMENT BASE TYPE: EMULSION BASE, OIL-IN-WATER
PRIMARY CONTAINER CONTENT QUANTITY: 3.000 OUNCES
PRIMARY CONTAINER TYPE: TUBE, COLLAPSIBLE
TOTAL PRIMARY CONTAINER QUANTITY: 12
Related Searches:
NDC45802-0174-53
METHYL SALICYLATE AND MENTHOL OINTMENT
NSN, MFG P/N
6505011561680
NSN
6505-01-156-1680
NDC45802-0174-53
METHYL SALICYLATE AND MENTHOL OINTMENT
NSN, MFG P/N
6505011561680
NSN
6505-01-156-1680
MFG
AMERISOURCEBERGEN DRUG CORPORATION DIV CORPORATE OFFICE
Description
ACTIVE INGREDIENT AND STRENGTH: 15.000 METHYL SALICYLATE PERCENTAGE, W/W AND 10.000 MENTHOL PERCENTAGE, W/W
III PART NAME ASSIGNED BY CONTROLLING AGENCY: METHYL SALICYLATE AND MENTHOL OINTMENT 3OZ (85 GRAM) 12S
MEDICAMENT BASE TYPE: EMULSION BASE, OIL-IN-WATER
PRIMARY CONTAINER CONTENT QUANTITY: 3.000 OUNCES
PRIMARY CONTAINER TYPE: TUBE, COLLAPSIBLE
TOTAL PRIMARY CONTAINER QUANTITY: 12